D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 76 Citations 16,093 412 World Ranking 14224 National Ranking 460

Overview

What is he best known for?

The fields of study Hideki Fujii is best known for:

  • Gene
  • Cancer
  • Immune system

The Genetics research Hideki Fujii does as part of his general Gene study is frequently linked to other disciplines of science, such as Cancer research, therefore creating a link between diverse domains of science. He incorporates Genetics and Gene in his studies. Hideki Fujii merges many fields, such as Cancer research and Cancer, in his writings. While working on this project, he studies both Cancer and Metastasis. His multidisciplinary approach integrates Internal medicine and Oncology in his work. In his research, he undertakes multidisciplinary study on Immunology and Immune system. Hideki Fujii conducted interdisciplinary study in his works that combined Immune system and Immunology. He carries out multidisciplinary research, doing studies in Pathology and Immunohistochemistry. He merges Immunohistochemistry with Pathology in his study.

His most cited work include:

  • Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells (1623 citations)
  • Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis (467 citations)
  • CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer (300 citations)

What are the main themes of his work throughout his whole career to date

Gastroenterology, Endocrinology, Pathology and Radiology are fields of study that intersect with his Internal medicine research. He undertakes multidisciplinary studies into Endocrinology and Internal medicine in his work. He merges Pathology with Cancer in his study. His Biochemistry study frequently draws connections between adjacent fields such as In vitro. As part of his studies on In vitro, he often connects relevant subjects like Biochemistry. He undertakes interdisciplinary study in the fields of Immunology and Immune system through his works. In his study, he carries out multidisciplinary Immune system and Immunology research. With his scientific publications, his incorporates both Cancer research and Cancer. His Fatty liver research extends to the thematically linked field of Disease.

Hideki Fujii most often published in these fields:

  • Internal medicine (75.12%)
  • Gastroenterology (29.60%)
  • Biochemistry (28.86%)

What were the highlights of his more recent work (between 2019-2022)?

  • Internal medicine (84.62%)
  • Disease (50.00%)
  • Gastroenterology (42.31%)

In recent works Hideki Fujii was focusing on the following fields of study:

His Fatty liver investigation overlaps with other areas such as Nonalcoholic fatty liver disease and Steatohepatitis. He applies his multidisciplinary studies on Steatohepatitis and Fatty liver in his research. His Internal medicine study often links to related topics such as Cirrhosis. Many of his studies involve connections with topics such as Nonalcoholic fatty liver disease and Disease. In his articles, Hideki Fujii combines various disciplines, including Gastroenterology and Endocrinology. He applies his multidisciplinary studies on Endocrinology and Diabetes mellitus in his research. Diabetes mellitus and Disease are two areas of study in which he engages in interdisciplinary work. He integrates many fields, such as Hepatocellular carcinoma and Sorafenib, in his works. Borrowing concepts from Hepatocellular carcinoma, Hideki Fujii weaves in ideas under Sorafenib.

Between 2019 and 2022, his most popular works were:

  • Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma (36 citations)
  • Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis (36 citations)
  • Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients (29 citations)

In his most recent research, the most cited works focused on:

  • Diabetes mellitus
  • Cancer
  • Immune system

In most of his Internal medicine studies, his work intersects topics such as Fibrosis. His Internal medicine research extends to the thematically linked field of Fibrosis. He integrates Endocrinology with Gastroenterology in his study. Hideki Fujii conducts interdisciplinary study in the fields of Gastroenterology and Endocrinology through his works. His Dyslipidemia research extends to the thematically linked field of Disease. Dyslipidemia and Disease are commonly linked in his work. In his research, Hideki Fujii undertakes multidisciplinary study on Biochemistry and Molecular biology. His study deals with a combination of Molecular biology and Cell biology. He combines topics linked to NOX4 with his work on Cell biology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Increased Populations of Regulatory T Cells in Peripheral Blood and Tumor-Infiltrating Lymphocytes in Patients with Gastric and Esophageal Cancers

Fumiko Ichihara;Koji Kono;Akihiro Takahashi;Hiromichi Kawaida.
Clinical Cancer Research (2003)

688 Citations

CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.

Yoshiki Mizukami;Koji Kono;Yoshihiko Kawaguchi;Hidenori Akaike.
International Journal of Cancer (2008)

415 Citations

Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin

Mina Komuta;Bart Spee;Sara Vander Borght;Rita De Vos.
Hepatology (2008)

403 Citations

CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.

Koji Kono;Hiromichi Kawaida;Akihiro Takahashi;Hidemitsu Sugai.
Cancer Immunology, Immunotherapy (2006)

388 Citations

β-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection

Huatao Huang;Hideki Fujii;Anna Sankila;Betania M. Mahler-Araujo.
American Journal of Pathology (1999)

383 Citations

Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.

Jun Itakura;Toshiyuki Ishiwata;Helmut Friess;Hideki Fujii.
Clinical Cancer Research (1997)

327 Citations

Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis

Yoshihiro Edamoto;Akira Hara;Wojciech Biernat;Luigi Terracciano.
International Journal of Cancer (2003)

324 Citations

Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging

Katsuhiro Sano;Tomoaki Ichikawa;Utaroh Motosugi;Hironobu Sou.
Radiology (2011)

324 Citations

High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results

Tomoaki Ichikawa;Sukru Mehmet Erturk;Utarou Motosugi;Hironobu Sou.
American Journal of Roentgenology (2007)

301 Citations

High-B-Value Diffusion-Weighted MRI in Colorectal Cancer

Tomoaki Ichikawa;Sukru Mehmet Erturk;Utarou Motosugi;Hironobu Sou.
American Journal of Roentgenology (2006)

301 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hideki Fujii

Jeong Min Lee

Jeong Min Lee

Seoul National University

Publications: 59

Masatoshi Kudo

Masatoshi Kudo

Kindai University

Publications: 45

Ikuo Saiki

Ikuo Saiki

University of Toyama

Publications: 45

Yusuke Nakamura

Yusuke Nakamura

Japanese Foundation For Cancer Research

Publications: 40

Claude B. Sirlin

Claude B. Sirlin

University of California, San Diego

Publications: 33

Joon Koo Han

Joon Koo Han

Seoul National University Hospital

Publications: 26

Terumi Kamisawa

Terumi Kamisawa

Tokyo Metropolitan Komagome Hospital

Publications: 26

Byung Ihn Choi

Byung Ihn Choi

Seoul National University

Publications: 25

Svetomir N. Markovic

Svetomir N. Markovic

Mayo Clinic

Publications: 24

Yasuni Nakanuma

Yasuni Nakanuma

Kanazawa University

Publications: 24

Nobuyuki Enomoto

Nobuyuki Enomoto

University of Yamanashi

Publications: 24

Josep M. Llovet

Josep M. Llovet

University of Barcelona

Publications: 22

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 21

Yataro Daigo

Yataro Daigo

Shiga University of Medical Science

Publications: 21

Takamichi Murakami

Takamichi Murakami

Kobe University

Publications: 20

Masashi Fukayama

Masashi Fukayama

University of Tokyo

Publications: 20

Trending Scientists

Jane Hunter

Jane Hunter

University of Technology Sydney

Nicolas Galanis

Nicolas Galanis

Université de Sherbrooke

Susan Bull

Susan Bull

University of Oxford

Irina P. Beletskaya

Irina P. Beletskaya

Lomonosov Moscow State University

Dirk Maes

Dirk Maes

Research Institute for Nature and Forest

Cedric Notredame

Cedric Notredame

Pompeu Fabra University

Aaron G. Maule

Aaron G. Maule

Queen's University Belfast

Robert P. Mecham

Robert P. Mecham

Washington University in St. Louis

Jorge Guillén

Jorge Guillén

Spanish National Research Council

Akula Venkatram

Akula Venkatram

University of California, Riverside

Lance M. McCracken

Lance M. McCracken

Uppsala University

Marja-Kristiina Lerkkanen

Marja-Kristiina Lerkkanen

University of Jyväskylä

Nicole Leeper Piquero

Nicole Leeper Piquero

University of Miami

Angel M. Y. Lin

Angel M. Y. Lin

Simon Fraser University

Karol L. Kumpfer

Karol L. Kumpfer

University of Utah

Niv Drory

Niv Drory

The University of Texas at Austin

Something went wrong. Please try again later.